表观扩散系数预测局部晚期直肠癌新辅助放化疗反应
结果显示,较低的治疗前平均ADC值和高于界值的ΔADC%与更好的反应率及无进展生存相关。
要点
- 治疗前平均ADC界值0.94×10-3 mm2/s,灵敏度80.36%、特异度74.29%。
- ΔADC%界值26.0%,灵敏度73.21%、特异度77.14%。
- 低治疗前ADC与高ΔADC%均与更好反应率和PFS相关。
核心结论
- 治疗前平均ADC值和ΔADC%是局部晚期直肠癌新辅助放化疗肿瘤反应的潜在预测因子。
研究设计与样本
- 治疗前及新辅助放化疗结束后4周内行扩散加权磁共振成像,由两名放射科医生评估感兴趣区平均ADC值。
- 肿瘤反应按RECIST 1.1评估,用ROC曲线计算平均ADC及ΔADC%界值,卡方检验比较反应率,Kaplan-Meier法分析无进展生存。
主要发现
- 治疗前平均ADC界值为0.94×10-3 mm2/s(灵敏度80.36%,特异度74.29%)。
- ΔADC%界值为26.0%(灵敏度73.21%,特异度77.14%)。
- 较低治疗前平均ADC值者反应率更高(83.3% vs 29.7%,P<0.001),PFS更长(26.12 vs 17.70个月,P=0.004)。
- ΔADC%高于界值者反应率更高(83.7% vs 35.7%,P<0.001),PFS更长(26.93 vs 15.65个月,P=0.034)。
关键数值与推荐
- 治疗前平均ADC界值0.94×10-3 mm2/s,灵敏度80.36%、特异度74.29%。
- ΔADC%界值26.0%,灵敏度73.21%、特异度77.14%。
- 较低治疗前平均ADC值者反应率83.3% vs 29.7%(P<0.001),PFS 26.12 vs 17.70个月(P=0.004)。
- ΔADC%高于界值者反应率83.7% vs 35.7%(P<0.001),PFS 26.93 vs 15.65个月(P=0.034)。
临床怎么用
- 可基于治疗前平均ADC值和ΔADC%辅助预测局部晚期直肠癌新辅助放化疗的肿瘤反应和PFS。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with locally advanced rectal cancer generally have different response rates to preoperative neoadjuvant chemo-radiotherapy. This study investigated the value of the apparent diffusion coefficient (ADC) as a predictor to forecast the response to neoadjuvant chemo-radiotherapy in patients with locally advanced rectal cancer. METHODS: Ninety-one locally advanced rectal cancer patients who underwent neoadjuvant chemo-radiotherapy between 2015 and 2018 were enrolled. Diffusion-weighted magnetic resonance imaging was performed before treatment and within 4 weeks after the completion of neoadjuvant chemo-radiotherapy. Mean ADC values of regions of interest were evaluated by two radiologists. The tumor response was evaluated according to RESCIST 1.1. The cut-off value for the mean ADC and increasing percentage (ΔADC%) after neoadjuvant chemo-radiotherapy was calculated using the receiver operating characteristic curve. The response rate of pre-ADC and ΔADC% above/below the cut-off values was determined using the chi-square test, respectively. Primary tumor progression-free survival (PFS) was analyzed using the Kaplan-Meier method, based on the pre-ADC and ΔADC% cut-off values. RESULTS: The cut-off value of mean pre-ADC and ΔADC% was 0.94 × 10-3 mm2/s (80.36% sensitivity, 74.29% specificity) and 26.0% (73.21% sensitivity, 77.14% specificity), respectively. Lower mean pre-ADC values were related to a better response rate (83.3% vs 29.7%, P < 0.001) and PFS (26.12 vs 17.70 months, P = 0.004). ΔADC% above the cut-off value was also related to a better response rate (83.7% vs 35.7%, P < 0.001) and PFS (26.93 vs 15.65 months, P = 0.034). CONCLUSIONS: The mean ADC pre-treatment value and ΔADC% were potential predictors for the tumor response in locally advanced rectal cancer patients treated with neoadjuvant chemo-radiotherapy.
引用
- Zhao M, Zhao L, Yang H, et al. Apparent diffusion coefficient for the prediction of tumor response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer. Radiat Oncol. 2021. PMID: 33472660. doi:10.1186/s13014-020-01738-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。